HIGHLIGHTS
- who: Mingyu Li et al. from the Nanjing Medical University, China have published the article: Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy, in the Journal: (JOURNAL)
- what: This study showed that antiviral therapy could reverse ascites and the level of ALT and HBV DNA were risk factors of ascites re-compensation after antiviral therapy in patients with HBV-related decompensated cirrhosis of ascites.
- how: Among this study two-tailed P and amplt0.05 was considered statistically significant. The results showed that ALT (OR0.988 95%CI p . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.